Felodipine Tablet, Extended Release shortage
To Be Discontinued 4 presentations · 1 manufacturers · first FDA posting 2026-10-07 · last update 2026-10-07
Manufacturers: Par Health, USA LLC
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Felodipine, Tablet, Extended Release, 2.5 mg (NDC 0603-3581-21) | Par Health, USA LLC | To Be Discontinued | — | Discontinuation in the manufacturing of the drug product | Posted 10/07/2026 Updated 10/07/2026 Discontinued 10/01/2026 |
| Felodipine, Tablet, Extended Release, 2.5 mg (NDC 0603-3581-28) | Par Health, USA LLC | To Be Discontinued | — | Discontinuation in the manufacturing of the drug product | Posted 10/07/2026 Updated 10/07/2026 Discontinued 10/01/2026 |
| Felodipine, Tablet, Extended Release, 5 mg (NDC 0603-3582-21) | Par Health, USA LLC | To Be Discontinued | — | Discontinuation in the manufacturing of the drug product | Posted 10/07/2026 Updated 10/07/2026 Discontinued 10/01/2026 |
| Felodipine, Tablet, Extended Release, 5 mg (NDC 0603-3582-28) | Par Health, USA LLC | To Be Discontinued | — | Discontinuation in the manufacturing of the drug product | Posted 10/07/2026 Updated 10/07/2026 Discontinued 10/01/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)